- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 7, Pages 1617
Publisher
MDPI AG
Online
2021-06-28
DOI
10.3390/cells10071617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice
- (2021) Takeshi Kimura et al. Science Translational Medicine
- C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia
- (2019) Ravi Savarirayan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease
- (2019) Yusaku Matsuda et al. Molecular Therapy-Nucleic Acids
- FGF2-induced STAT3 activation regulates pathologic neovascularization
- (2019) Zhenyu Dong et al. EXPERIMENTAL EYE RESEARCH
- The FGF2 aptamer inhibits the growth of FGF2-FGFR pathway driven lung cancer cells
- (2018) Junko Hamamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aptamers as therapeutic middle molecules
- (2018) Yoshikazu Nakamura BIOCHIMIE
- A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration
- (2018) Amir H. Kashani et al. Science Translational Medicine
- Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model
- (2016) Davide Komla-Ebri et al. JOURNAL OF CLINICAL INVESTIGATION
- FGFR Signaling as a Target for Lung Cancer Therapy
- (2016) Arpita Desai et al. Journal of Thoracic Oncology
- Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain
- (2016) Ling Jin et al. MOLECULAR THERAPY
- Fit for the Eye: Aptamers in Ocular Disorders
- (2016) Daniel W. Drolet et al. Nucleic Acid Therapeutics
- Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis
- (2015) Alicja R. Rudnicka et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes
- (2015) Iva Gudernova et al. HUMAN MOLECULAR GENETICS
- Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis
- (2014) Sunday S. Oladipupo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
- (2014) Amy E. Birsner et al. Jove-Journal of Visualized Experiments
- FGFR3mutation frequency in 324 cases from the International Skeletal Dysplasia Registry
- (2014) Yuan Xue et al. Molecular Genetics & Genomic Medicine
- Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy
- (2013) Keijiro Ishikawa et al. FASEB JOURNAL
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Ebenezer Daniel et al. OPHTHALMOLOGY
- Mechanisms of FGFR-mediated carcinogenesis
- (2012) Imran Ahmad et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- FGF/FGFR signaling in bone formation: Progress and perspectives
- (2012) Pierre J. Marie et al. GROWTH FACTORS
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- CAUSES OF UNSUCCESSFUL RANIBIZUMAB TREATMENT IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN CLINICAL SETTINGS
- (2012) Salomon Y. Cohen et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)
- (2011) Khaled Nassar et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- Physical Basis behind Achondroplasia, the Most Common Form of Human Dwarfism
- (2010) Lijuan He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Conformational plasticity of RNA for target recognition as revealed by the 2.15 Å crystal structure of a human IgG–aptamer complex
- (2010) Yusuke Nomura et al. NUCLEIC ACIDS RESEARCH
- Occurrence of drusen, pigmentary changes and exudative changes in the macula with reference to age-related macular degeneration An epidemiological study of 1000 aged individuals
- (2009) Troels Vinding ACTA OPHTHALMOLOGICA
- Molecular pathology of the fibroblast growth factor family
- (2009) Pavel Krejci et al. HUMAN MUTATION
- Activation Transcription Factor-4 Induced by Fibroblast Growth Factor-2 Regulates Vascular Endothelial Growth Factor-A Transcription in Vascular Smooth Muscle Cells and Mediates Intimal Thickening in Rat Arteries Following Balloon Injury
- (2008) Kristine P. Malabanan et al. CIRCULATION RESEARCH
- FGF-2 signaling induces downregulation of TAZ protein in osteoblastic MC3T3-E1 cells
- (2007) Homare Eda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Direct and Indirect Actions of Fibroblast Growth Factor 2 on Osteoclastic Bone Resorption in Cultures
- (2006) Hiroshi Kawaguchi et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started